Inbox Robot: RSV News http://www.inboxrobot.com/news/rsv-respiratory-syncytial-virus Constantly updated news and information about a variety of topics. Oxoid introduces influenza tests http://www.inboxrobot.com/news.php?fid=201298276 2 Dec 2008 06:16 GMT ... of diagnostic tools for the detection of respiratory disease caused by influenza virus Types A and B. Rapid diagnosis of ... viral respiratory infections such as Influenza, Respiratory Syncytial Virus and are often difficult to differentiate ... FDA Issues Complete Response for MedImmune Lung Drug http://www.inboxrobot.com/news.php?fid=201292463 2 Dec 2008 04:51 GMT ... motavizumab (formerly Numax), a monoclonal antibody under investigation as a therapy to prevent serious respiratory syncytial virus (RSV) disease in pediatric patients. The drug is a next generation of Synagis (palivizumab), ... MedImmune Receives FDA Complete Response Letter on Motavizumab http://www.inboxrobot.com/news.php?fid=201256778 1 Dec 2008 23:31 GMT ... connection with the Biologics License Application (BLA) for motavizumab for the prevention of serious respiratory syncytial virus (RSV) disease, which was submitted on 30 January 2008. Motavizumab is an investigational monoclonal ... Biota Holdings Limited (ASX:BTA) Appoints Mr Richard Hill As Director http://www.inboxrobot.com/news.php?fid=201250343 1 Dec 2008 22:54 GMT ... in Melbourne Australia, with key expertise in respiratory diseases, particularly influenza. Biota developed the first- ... Biota developed the first- in-class neuraminidase inhibitor, zanamivir, subsequently marketed by GlaxoSmithKline as Relenza. Biota ... candidate drugs aimed at treatment of respiratory syncytial virus (RSV) disease, licensed to MedImmune Inc. ... It's Wait Until Next Year for These Drugmakers http://www.inboxrobot.com/news.php?fid=201224216 1 Dec 2008 20:51 GMT ... will have different effects on the companies. a complete response letter for motavizumab, its respiratory syncytial virus (RSV) prophylactic. AstraZeneca didn't say what problems the agency had with its marketing application, ... Quidel to Present at the 20th Annual Piper Jaffray Healthcare Conference http://www.inboxrobot.com/news.php?fid=201209584 1 Dec 2008 19:20 GMT ... tests that aid in the diagnosis of several disease or condition states, including influenza, respiratory syncytial virus, Fecal Occult Blood, Strep A, pregnancy, bacterial vaginosis, H. pylori and Chlamydia. Quidel's products ... First Ever In-vivo Efficacy Data For A MicroRNA Therapeutic Disease Model http://www.inboxrobot.com/news.php?fid=201197395 1 Dec 2008 18:24 GMT ... lab of Dr. Stefan Engelhardt at the Virchow Center at the University of Wuerzburg, working ... human clinical trials for the treatment of respiratory syncytial virus (RSV) infection. In addition, the company ... Common Cold Virus Came From Birds http://www.inboxrobot.com/news.php?fid=201185208 1 Dec 2008 16:51 GMT ... December 01, 2008 at 10:42:13 am A virus that causes cold-like symptoms in humans originated ... the second most common cause of lower respiratory infection in young children. Studies have shown ... Human metapneumovirus is related to the respiratory syncytial virus, measles, mumps and parainfluenza viruses. It ... AstraZeneca's New Lung Drug Motavizumab Faces US Delay On FDA Request For More Data http://www.inboxrobot.com/news.php?fid=201113801 1 Dec 2008 08:31 GMT ... in the United States. AstraZeneca had been planning to get Motavizumab, used to prevent respiratory syncytial virus, to market in the second half of 2009, in time to catch the next ... DeVincenzo's career focuses on respiratory syncytial virus research http://www.inboxrobot.com/news.php?fid=201091658 1 Dec 2008 06:11 GMT ... Since the early days of his career, John DeVincenzo has focused his research on respiratory syncytial virus. Today, many eyes are watching his work at Le Bonheur Children’s Medical Center. DeVincenzo’s ... Regulus Therapeutics, Alnylam Pharmaceuticals, and Collaborators Publish First Ever In Vivo Efficacy Data for a http://www.inboxrobot.com/news.php?fid=201040477 30 Nov 2008 19:14 GMT ... lab of Dr. Stefan Engelhardt at the Virchow Center at the University of Wuerzburg, working ... human clinical trials for the treatment of respiratory syncytial virus (RSV) infection. In addition, the company ... Regulus Therapeutics, Alnylam Pharmaceuticals, and Collaborators Publish First Ever In Vivo Efficacy Data for a microRNA Therapeutic in a Disease Model http://www.inboxrobot.com/news.php?fid=201037255 30 Nov 2008 18:30 GMT ... lab of Dr. Stefan Engelhardt at the Virchow Center at the University of Wuerzburg, working ... human clinical trials for the treatment of respiratory syncytial virus (RSV) infection. In addition, the company ... National And International Report / Fed lending more through emergency program http://www.inboxrobot.com/news.php?fid=200999997 30 Nov 2008 08:30 GMT ... lung infection in babies. AstraZeneca had been planning to get Motavizumab, used to prevent respiratory syncytial virus, to market in the second half of 2009 in time to catch the ... Common Cold Virus Came From Birds About 200 Years Ago, Study Suggests http://www.inboxrobot.com/news.php?fid=200962147 29 Nov 2008 23:15 GMT ... "Human metapneumovirus may be the second most common cause of lower respiratory infection in young children. Studies have shown ... Human metapneumovirus is related to the respiratory syncytial virus, measles, mumps and parainfluenza viruses. It ... Common Cold Virus Came From Birds? http://www.inboxrobot.com/news.php?fid=200960649 29 Nov 2008 22:53 GMT ... "Human metapneumovirus may be the second most common cause of lower respiratory infection in young children. Studies have shown ... Human metapneumovirus is related to the respiratory syncytial virus, measles, mumps and parainfluenza viruses. It ...